Arthrogen Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$621K
Arthrogen General Information
Description
Developer of a local gene therapy intended for different indications, using viral-mediated gene transfer. The company specializes in the development of viral gene therapy vectors, in particular, adeno-associated virus (AAV-) based therapeutics, enabling health professionals to cure inflammatory diseases.
Contact Information
Website
www.arthrogen.nlCorporate Office
- Meibergdreef 45
- 1105 BA Amsterdam
- Netherlands
Corporate Office
- Meibergdreef 45
- 1105 BA Amsterdam
- Netherlands
Arthrogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 17-Oct-2019 | $621K | Completed | Generating Revenue | ||
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. Joint Venture | 01-Jan-2005 | Completed | Generating Revenue |
Arthrogen Patents
Arthrogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019141765-A1 | A modified raav capsid protein for gene therapy | Inactive | 17-Jan-2018 | ||
| AU-2015330092-A1 | Aav-based gene therapy | Inactive | 06-Oct-2014 | ||
| EP-3204503-A1 | Aav-based gene therapy | Inactive | 06-Oct-2014 | ||
| US-20170304466-A1 | Aav-based gene therapy | Inactive | 06-Oct-2014 | ||
| WO-2016055437-A1 | Aav-based gene therapy | Inactive | 06-Oct-2014 | A61K48/0083 |
Arthrogen Signals
Arthrogen Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amsterdam UMC Ventures Holding | Venture Capital | Minority | ||
| Dubai Bone & Joint Center | Corporation | Majority | ||
| The Academic Medical Center | Corporation | Majority | ||
| UvA Ventures Holding | Venture Capital | Minority |
Arthrogen FAQs
-
When was Arthrogen founded?
Arthrogen was founded in 2005.
-
Where is Arthrogen headquartered?
Arthrogen is headquartered in Amsterdam, Netherlands.
-
What is the size of Arthrogen?
Arthrogen has 15 total employees.
-
What industry is Arthrogen in?
Arthrogen’s primary industry is Drug Discovery.
-
Is Arthrogen a private or public company?
Arthrogen is a Private company.
-
What is the current valuation of Arthrogen?
The current valuation of Arthrogen is .
-
What is Arthrogen’s current revenue?
The current revenue for Arthrogen is .
-
Who are Arthrogen’s investors?
Amsterdam UMC Ventures Holding, Dubai Bone & Joint Center, The Academic Medical Center, and UvA Ventures Holding have invested in Arthrogen.
-
When was Arthrogen acquired?
Arthrogen was acquired on 17-Oct-2019.
-
Who acquired Arthrogen?
Arthrogen was acquired by MeiraGTx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process